Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 2 | 50% |
Novel peptide therapies to treat inflammatory bowel disease (IBD) and necrotizing enterocolitis (NEC).
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Accelerator & incubator | 1 | 25% |
| Other / undisclosed | 2 | 50% |